Clinical Trial Update: Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of adjuvant temozolomide plus TTFields (Optune) and pembrolizumab in newly diagnosed glioblastoma; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• OPTUNE
• Pembrolizumab (pembrolizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: University of Florida | Conditions: Glioblastoma, Glioblastoma, WHO Grade IV | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-04-15